Emergex
  • About Us
      • Team
      • Board of Directors
      • Special Advisors
  • Technology
      • Advantages of Emergex’s Vaccines
      • Set-point Vaccines
  • Pipeline
  • Media Centre
      • Press Releases
      • In the News
      • White Papers
  • Contact Us
  • Menu Menu
You are here: Home1 / Technology2 / Set-point Vaccines

We have developed the first approach to making set-point vaccines using experimentally selected purely synthetic non-biological components that program immune cells to destroy pathogen producing cells.

These vaccines modify the initial immune status of the recipients in a way that ‘primes’ their immune systems to recognise subsequent infectious agents much like a natural infection would do, and thus preventing an acute or severe manifestation of the disease.

Learn more about the advantages of our technology

© EMERGEX VACCINES

Website maintained by Digital Trading

  • Contact Us
LinkedIn
Scroll to top